LivaNova (LIVN) Total Current Liabilities (2015 - 2026)
LivaNova's (LIVN) quarterly Total Current Liabilities came in at $762.5 million in Q1 2026, up 2.82% year-on-year from $741.6 million in Q1 2025, and down 5.64% quarter-over-quarter from $808.1 million in Q4 2025.
LivaNova (LIVN) Total Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Total Current Liabilities across 12 years of filings, most recently posting $762.5 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $762.5 million, up 2.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $762.5 million (up 2.82% YoY), and the FY2025 annual result was $808.1 million, up 106.08% from the prior year.
- Total Current Liabilities came in at $762.5 million for Q1 2026 at LivaNova, down from $808.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $827.6 million in Q3 2025 to a low of $263.9 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $324.4 million (2024), against an average of $453.3 million.
- Across the five-year window, Total Current Liabilities slumped 62.42% in 2022 and jumped 172.98% in 2025, its largest moves.
- LivaNova's Total Current Liabilities stood at $297.4 million in 2022, then increased by 12.64% to $335.0 million in 2023, then gained by 17.06% to $392.1 million in 2024, then soared by 106.08% to $808.1 million in 2025, then declined by 5.64% to $762.5 million in 2026.
- The last three Total Current Liabilities figures came in at $762.5 million (Q1 2026), $808.1 million (Q4 2025), and $827.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 762.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 762.48 Mn |
| Dec 31, 2025 | 808.07 Mn |
| Sep 30, 2025 | 827.59 Mn |
| Jun 30, 2025 | 827.10 Mn |
| Mar 31, 2025 | 741.57 Mn |
| Dec 31, 2024 | 392.13 Mn |
| Sep 30, 2024 | 324.40 Mn |
| Jun 30, 2024 | 302.99 Mn |
| Mar 31, 2024 | 327.77 Mn |
| Dec 31, 2023 | 334.98 Mn |
| Sep 30, 2023 | 295.40 Mn |
| Jun 30, 2023 | 288.16 Mn |
| Mar 31, 2023 | 316.13 Mn |
| Dec 31, 2022 | 297.40 Mn |
| Sep 30, 2022 | 288.02 Mn |
| Jun 30, 2022 | 263.89 Mn |
| Mar 31, 2022 | 307.91 Mn |
| Dec 31, 2021 | 696.97 Mn |
| Sep 30, 2021 | 658.47 Mn |
| Jun 30, 2021 | 702.25 Mn |